Related Experiment Video
Updated: Jun 8, 2026

Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD)
Published on: September 13, 2018
The need for quality improvement in sweat testing infants after newborn screening for cystic fibrosis
Vicky A Legrys1, Susanna A McColley, Zhanhai Li
1School of Medicine, Division of Clinical Laboratory Science, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Insights
Newborn screening for cystic fibrosis often results in insufficient sweat tests, occurring in 7.2% of infants. This high rate highlights the need for improved quality control in cystic fibrosis diagnosis.
Area of Science:
- Pediatrics
- Genetics
- Medical Diagnostics
Background:
- Newborn screening programs aim for early detection of genetic disorders like cystic fibrosis.
- Accurate diagnostic testing is crucial following positive newborn screening results.
Purpose of the Study:
- To determine the proportion of insufficient sweat tests in infants following positive newborn screening for cystic fibrosis.
- To identify factors influencing sweat test adequacy in this population.
Main Methods:
- Retrospective analysis of sweat test results in infants with positive newborn screening for cystic fibrosis.
- Data collection on infant age and sweat sample collection methods.
Main Results:
- The mean rate of insufficient sweat tests was 7.2% (± 7.6%), with a wide range (0% to 40%).
- Infant age (≤ 3 months) was considered in the analysis.
- Sweat collection methods did not significantly impact the rate of insufficient tests.
Conclusions:
- High and variable rates of insufficient sweat tests pose a challenge in confirming cystic fibrosis diagnoses post-newborn screening.
- There is a clear need for quality improvement initiatives to enhance the reliability of sweat testing in infants.
Abstract:
The proportion of insufficient sweat tests after positive newborn screening for cystic fibrosis was determined. Infants ≤ 3 months old had a mean (± standard deviation) rate of 7.2% (± 7.6) (range, 0% to 40%). Collection methods did not affect the rates. The high and variable rates indicate a need for quality improvement.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...